Infliximab-induced lupus-like syndrome in a patient with ankylosing spondylitis.

Rheumatology International
Hatice BodurSerpil Arikan

Abstract

Infliximab is a chimerical monoclonal antibody currently used in the treatment of various inflammatory diseases. Lupus-like syndrome is a rarely reported adverse event, and generally observed in rheumatoid arthritis cases. We hereby define and describe a case of a lupus-like syndrome, which developed following the 4th infliximab infusion in a 62-year-old patient with ankylosing spondylitis (AS). As far as we acknowledge, the present case is the third AS case with infliximab-induced lupus.

References

May 19, 2005·Arthritis Research & Therapy·Michel De BandtUNKNOWN Club Rhumatismes et Inflammation
Oct 18, 2006·Journal of Korean Medical Science·Min-Jung KangJisoo Lee
Jul 17, 2007·Medicine·Manuel Ramos-CasalsMunther A Khamashta
Oct 2, 2007·Arthritis and Rheumatism·Lyndell L LimJames T Rosenbaum
Nov 21, 2007·Annals of the Rheumatic Diseases·D E FurstM E Weinblatt
Dec 7, 2007·Annals of the Rheumatic Diseases·D van der HeijdeUNKNOWN ATLAS Study Group

❮ Previous
Next ❯

Citations

Aug 21, 2013·Clinical Rheumatology·Tânia SantiagoJosé António Pereira da Silva
Aug 10, 2010·Clinics in Chest Medicine·Naveen Kanathur, Teofilo Lee-Chiong
Mar 9, 2012·Autoimmune Diseases·Oscar M Pérez-FernándezJuan-Manuel Anaya
Nov 13, 2013·Revista brasileira de reumatologia·João Luiz Pereira VazRoger Abramino Levy
Aug 8, 2014·Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists·Cigdem OzkanNuri Cakir

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.